[go: up one dir, main page]

FI952260L - Propiofenonijohdos ja menetelmä sen valmistamiseksi - Google Patents

Propiofenonijohdos ja menetelmä sen valmistamiseksi Download PDF

Info

Publication number
FI952260L
FI952260L FI952260A FI952260A FI952260L FI 952260 L FI952260 L FI 952260L FI 952260 A FI952260 A FI 952260A FI 952260 A FI952260 A FI 952260A FI 952260 L FI952260 L FI 952260L
Authority
FI
Finland
Prior art keywords
preparation
propiophenone derivative
propiophenone
derivative
Prior art date
Application number
FI952260A
Other languages
English (en)
Swedish (sv)
Other versions
FI952260A0 (fi
FI116975B (fi
Inventor
Kenji Tsujihara
Mitsuya Hongu
Nobuyuki Funami
Masanori Inmasu
Kenji Arakawa
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of FI952260A0 publication Critical patent/FI952260A0/fi
Publication of FI952260L publication Critical patent/FI952260L/fi
Application granted granted Critical
Publication of FI116975B publication Critical patent/FI116975B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
FI952260A 1994-05-11 1995-05-10 Propiofenonijohdannainen ja menetelmä sen valmistamiseksi FI116975B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP9680594 1994-05-11
JP9680594 1994-05-11
JP28234494 1994-11-17
JP28234494 1994-11-17

Publications (3)

Publication Number Publication Date
FI952260A0 FI952260A0 (fi) 1995-05-10
FI952260L true FI952260L (fi) 1995-11-12
FI116975B FI116975B (fi) 2006-04-28

Family

ID=26437976

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952260A FI116975B (fi) 1994-05-11 1995-05-10 Propiofenonijohdannainen ja menetelmä sen valmistamiseksi

Country Status (15)

Country Link
US (1) US5830873A (fi)
EP (1) EP0684254B1 (fi)
KR (1) KR100318793B1 (fi)
CN (1) CN1042637C (fi)
AT (1) ATE178069T1 (fi)
AU (1) AU680118B2 (fi)
BR (1) BR9502016A (fi)
CA (1) CA2149160C (fi)
DE (1) DE69508463T2 (fi)
DK (1) DK0684254T3 (fi)
ES (1) ES2133614T3 (fi)
FI (1) FI116975B (fi)
GR (1) GR3029795T3 (fi)
IL (1) IL113581A (fi)
MY (1) MY119134A (fi)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1020944C (zh) 1990-01-30 1993-05-26 阿图尔-费希尔股份公司费希尔厂 紧固件
JP3059088B2 (ja) * 1995-11-07 2000-07-04 田辺製薬株式会社 プロピオフェノン誘導体およびその製法
DE69712172T2 (de) * 1996-12-26 2002-10-31 Tanabe Seiyaku Co., Ltd. Propiophenonderivate und Verfahren zu ihrer Herstellung
PH12000002657B1 (en) 1999-10-12 2006-02-21 Bristol Myers Squibb Co C-aryl glucoside SGLT2 inhibitors
US6515117B2 (en) 1999-10-12 2003-02-04 Bristol-Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
US6555519B2 (en) 2000-03-30 2003-04-29 Bristol-Myers Squibb Company O-glucosylated benzamide SGLT2 inhibitors and method
US6683056B2 (en) 2000-03-30 2004-01-27 Bristol-Myers Squibb Company O-aryl glucoside SGLT2 inhibitors and method
US6936590B2 (en) 2001-03-13 2005-08-30 Bristol Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
CA2443325C (en) * 2001-04-04 2011-06-14 Ortho-Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
ES2321815T3 (es) 2001-04-04 2009-06-12 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Combinacion terapeutica que comprende inhibidores de reabsorcion e glucosa y moduladores ppar.
DE10258007B4 (de) * 2002-12-12 2006-02-09 Sanofi-Aventis Deutschland Gmbh Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
TW200504021A (en) 2003-01-24 2005-02-01 Bristol Myers Squibb Co Substituted anilide ligands for the thyroid receptor
WO2005012242A2 (en) * 2003-08-01 2005-02-10 Janssen Pharmaceutica Nv Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
US8785403B2 (en) 2003-08-01 2014-07-22 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
AU2004261264A1 (en) 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted indazole-O-glucosides
TW200521131A (en) * 2003-08-01 2005-07-01 Janssen Pharmaceutica Nv Substituted fused heterocyclic c-glycosides
PL1651658T5 (pl) * 2003-08-01 2020-11-30 Mitsubishi Tanabe Pharma Corporation Nowe związki o działaniu inhibitującym transporter zależny od sodu
AR048282A1 (es) * 2003-08-01 2006-04-19 Janssen Pharmaceutica Nv Indol- o - glucosidos sustituidos
TW200606129A (en) 2004-07-26 2006-02-16 Chugai Pharmaceutical Co Ltd Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
TW200637869A (en) 2005-01-28 2006-11-01 Chugai Pharmaceutical Co Ltd The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
AR053329A1 (es) * 2005-01-31 2007-05-02 Tanabe Seiyaku Co Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
MY147375A (en) * 2005-01-31 2012-11-30 Mitsubishi Tanabe Pharma Corp Indole derivatives
TWI418556B (zh) * 2006-07-27 2013-12-11 Mitsubishi Tanabe Pharma Corp 吲哚衍生物
UY30730A1 (es) * 2006-12-04 2008-07-03 Mitsubishi Tanabe Pharma Corp Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
WO2008070609A1 (en) * 2006-12-04 2008-06-12 Janssen Pharmaceutica N.V. Thienyl-containing glycopyranosyl derivatives as antidiabetics
MX2010002695A (es) 2007-09-10 2010-04-01 Janssen Pharmaceutica Nv Proceso para la preparacion de compuestos utiles como inhibidores de transportador de glucosa dependiente de sodio (sglt).
CL2008003653A1 (es) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
US8791077B2 (en) 2008-05-22 2014-07-29 Astrazeneca Ab Method for treating hyperuricemia employing an SGLT2 inhibitor and composition containing same
US9056850B2 (en) * 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US20110009347A1 (en) * 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
CA2767258C (en) 2009-07-10 2016-09-13 Janssen Pharmaceutica Nv Crystallisation process for 1-(.beta.-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl] benzene
CA2777528C (en) * 2009-10-14 2018-09-18 Janssen Pharmaceutica Nv Process for the preparation of compounds useful as inhibitors of sglt2
CN102883726A (zh) 2010-05-11 2013-01-16 詹森药业有限公司 包含1-(β-D-吡喃葡萄糖基)-2-噻吩基-甲基苯衍生物作为SGLT抑制剂的药物制剂
CN103596944B (zh) 2011-04-13 2017-02-22 詹森药业有限公司 可用作sglt2的抑制剂的化合物的制备方法
TWI542596B (zh) 2011-05-09 2016-07-21 健生藥品公司 （２ｓ,３ｒ,４ｒ,５ｓ,６ｒ）－２－（３－（（５－（４－氟苯基）噻吩－２－基）甲基）－４－甲基苯基）－６－（羥甲基）四氫－２ｈ－哌喃－３,４,５－三醇之ｌ－脯胺酸及檸檬酸共晶體
US20170071970A1 (en) 2015-09-15 2017-03-16 Janssen Pharmaceutica Nv Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
AU2019304032B2 (en) 2018-07-19 2021-12-09 Astrazeneca Ab Methods of treating HFpEF employing dapagliflozin and compositions comprising the same
CN114209689B (zh) 2020-07-27 2023-02-17 阿斯利康(瑞典)有限公司 用达格列净治疗慢性肾脏病的方法
HUE073485T2 (hu) 2020-07-27 2026-01-28 Astrazeneca Ab Dapagliflozin krónikus vesebetegség kezelésére szolgáló eljárásokban történõ alkalmazásra
US20240212818A1 (en) 2021-04-01 2024-06-27 Astrazeneca Uk Limited Systems and methods for managing prediabetes with a gliflozin sodiumglucose cotransport 2 inhibitor pharmaceutical composition
JP2025503136A (ja) 2022-01-26 2025-01-30 アストラゼネカ・アクチエボラーグ 前糖尿病の治療又は２型糖尿病の発症リスクを低減する際に使用するためのダパグリフロジン
WO2025125513A1 (en) 2023-12-15 2025-06-19 AstraZeneca Ireland Limited Sglt2 inhibitors and baxdrostat for treating chronic kidney disease and hypertension

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984394A (en) * 1971-05-14 1976-10-05 Nutrilite Products, Inc. Salts of dihydrochalcone derivatives and their use as sweeteners
US4031260A (en) * 1971-05-14 1977-06-21 Nutrilite Products, Inc. Salts of dihydrochalcone derivatives and their use as sweeteners
US4049715A (en) * 1973-10-01 1977-09-20 Sterling Drug Inc. 3-[2-(4-Anisidino)phenyl]-1-phenyl-1-propiophenones and propanols
US4684627A (en) * 1981-09-08 1987-08-04 Leveen Harry H Treatment of cancer with phlorizin and its derivatives
US5110801A (en) * 1984-08-13 1992-05-05 Leveen Harry H Treatment of acne
CA1289077C (en) * 1984-08-13 1991-09-17 Harry H. Leveen Treatment of cancer with phlorizin and its derivatives
US4760135A (en) * 1984-09-06 1988-07-26 University Of Kentucky Research Foundation Phloretin and phlorizin derivative containing compounds
US4665058A (en) * 1985-03-16 1987-05-12 The University Of Kentucky Research Foundation Compositions and method of treatment for sickle cell anemia
CA2102591C (en) * 1992-11-12 2000-12-26 Kenji Tsujihara Hypoglycemic agent

Also Published As

Publication number Publication date
AU1779095A (en) 1995-11-16
CA2149160A1 (en) 1995-11-12
CA2149160C (en) 2002-01-29
MY119134A (en) 2005-04-30
FI952260A0 (fi) 1995-05-10
DK0684254T3 (da) 1999-10-11
GR3029795T3 (en) 1999-06-30
FI116975B (fi) 2006-04-28
ES2133614T3 (es) 1999-09-16
US5830873A (en) 1998-11-03
ATE178069T1 (de) 1999-04-15
BR9502016A (pt) 1995-12-12
EP0684254A1 (en) 1995-11-29
DE69508463T2 (de) 1999-08-19
AU680118B2 (en) 1997-07-17
KR100318793B1 (ko) 2002-07-04
DE69508463D1 (de) 1999-04-29
CN1042637C (zh) 1999-03-24
IL113581A (en) 1999-07-14
CN1121925A (zh) 1996-05-08
EP0684254B1 (en) 1999-03-24
KR950032262A (ko) 1995-12-20
IL113581A0 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
FI952260L (fi) Propiofenonijohdos ja menetelmä sen valmistamiseksi
FI951184A7 (fi) Taikinaa sisältävä yhdistelmä sekä menetelmä sen valmistamiseksi
FI960751A7 (fi) Substituoidut atsaindolylideeniyhdisteet ja menetelmä niiden valmistamiseksi
FI973426L (fi) Bentsopyraania sisältävät yhdisteet ja menetelmä niiden valmistamiseksi
FI980043A7 (fi) Ääntä vaimentava tuote ja menetelmä sen valmistamiseksi
NO976072D0 (no) Propiofenonderivater og fremgangsmåte for fremstilling derav
FI956270L (fi) Piperdiinijohdannaisia ja menetelmä niiden valmistamiseksi
FI941137L (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI973733L (fi) Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
FI952616L (fi) Työkalu ja menetelmä sen valmistamiseksi
FI972164L (fi) Aerogeelipitoinen komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö
FI972165L (fi) Aerogeelipitoinen komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö
FI970518A7 (fi) Majoneesin tapainen tuote ja menetelmä sen valmistamiseksi
FI973102L (fi) Menetelmä modifioitujen aerogeelien valmistamiseksi ja niiden käytt¦
FI956080L (fi) Kuidutettu selluloosatuote ja menetelmä sen valmistamiseksi
FI964102L (fi) Menetelmä fenolin ja fenolijohdannaisten valmistamiseksi
FI951468L (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
FI960517L (fi) Kosteita pastatyyppisiä ruoka-aineita ja menetelmä niiden valmistamiseksi
FI964310A7 (fi) Imidatsolijohdannainen ja menetelmä sen valmistamiseksi
FI955076A7 (fi) Elintarviketuote ja menetelmä sen valmistamiseksi
FI942298A0 (fi) Menetelmä ja sovitelma tilaelementtien siirtämiseksi
FI973434A7 (fi) Aminotetralonijohdannaisia ja menetelmä niiden valmistamiseksi
FI955123A0 (fi) Kolestyramiinia sisältävä koostumus ja menetelmä tämän valmistamiseksi
FI955399L (fi) Polyolikoostumus, menetelmä sen valmistamiseksi ja sen käytöt
FI972464L (fi) Diaminoeetterin diklavulanaattisuola ja menetelmä sen valmistamiseksi

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116975

Country of ref document: FI

MA Patent expired